1. Pathologic response at interval debulking surgery following neoadjuvant chemotherapy predicts improved survival in women with ovarian cancer 
E.N. Prendergast, M.I. Liang, J.N. Staples, J. Lester, A.J. Li, C. Walsh, B.J. Rimel, R.S. Leuchter, B.Y. Karlan, I. Cass 
Gynecologic Oncology 
Volume 141, Pages (June 2016)
DOI: /j.ygyno
Copyright © Terms and Conditions

2. Fig. 1
Complete Pathologic Response at the Time of Interval Debulking Surgery Following Neoadjuvant Chemotherapy is Associated with Improvided Progression.
Gynecologic Oncology  , DOI: ( /j.ygyno )
Copyright © Terms and Conditions